Access Resources
1731 - 1740 of 7540 Results
Title
Year
-
RESTRICTEDTitle: Production of Recombinant Alpha-Synuclein: Still No Standardized Protocol in SightJournal Name: BiomoleculesPublisher: MDPI AGVol: 12Issue #: 2Start Page: 324End Page: 324Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom12020324Best OA location URL: https://www.mdpi.com/2218-273X/12/2/324/pdf?version=1645168040Citation Count: 5
- Astrocytic α2-Na + /K + ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse model2022RESTRICTEDTitle: Astrocytic α2-Na + /K + ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse modelJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 632Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.abm4107Best OA location URL: https://www.science.org/doi/pdf/10.1126/scitranslmed.abm4107?download=trueCitation Count: 36
-
RESTRICTEDTitle: Determinants of Self-Stigma in People with Parkinson’s Disease: A Mixed Methods Scoping ReviewJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 2Start Page: 509End Page: 522Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-212869Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212869?id=journal-of-parkinsons-disease%2Fjpd212869Citation Count: 9
- Neuromelanin‐MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template‐Based Standardized Analysis2022RESTRICTEDTitle: Neuromelanin‐MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template‐Based Standardized AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1028End Page: 1039Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28934Best OA location URL: https://eprints.ncl.ac.uk/file_store/production/280599/F8D25577-4BD4-4869-B17B-5EA85CDD87CE.pdfCitation Count: 13
- Olfactory dysfunction is associated with motor function only in tremor-dominant Parkinson’s disease2022RESTRICTEDTitle: Olfactory dysfunction is associated with motor function only in tremor-dominant Parkinson’s diseaseJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 7Start Page: 4193End Page: 4201Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10072-022-05952-wCitation Count: 7
- Pedunculopontine and Cuneiform Nuclei Deep Brain Stimulation for Severe Gait and Balance Disorders in Parkinson’s Disease: Interim Results from a Randomized Double-Blind Clinical Trial2022RESTRICTEDTitle: Pedunculopontine and Cuneiform Nuclei Deep Brain Stimulation for Severe Gait and Balance Disorders in Parkinson’s Disease: Interim Results from a Randomized Double-Blind Clinical TrialJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 2Start Page: 639End Page: 653Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-212793Best OA location URL: https://hal.sorbonne-universite.fr/hal-03962391/file/Bourilhon%2CJParkDis_2021.pdfCitation Count: 6
- Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial2022RESTRICTEDTitle: Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD TrialJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 2Start Page: 557End Page: 570Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212714Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212714?id=journal-of-parkinsons-disease%2Fjpd212714Citation Count: 34
- S-Nitrosylation of p62 Inhibits Autophagic Flux to Promote α-Synuclein Secretion and Spread in Parkinson's Disease and Lewy Body Dementia2022RESTRICTEDTitle: S-Nitrosylation of p62 Inhibits Autophagic Flux to Promote α-Synuclein Secretion and Spread in Parkinson's Disease and Lewy Body DementiaJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 42Issue #: 14Start Page: 3011End Page: 3024Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/jneurosci.1508-21.2022Best OA location URL: https://www.jneurosci.org/content/jneuro/42/14/3011.full.pdfCitation Count: 22
-
RESTRICTEDTitle: Trait Anxiety as a Risk Factor for Impulse Control Disorders in de novo Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 2Start Page: 689End Page: 697Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212959Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212959?id=journal-of-parkinsons-disease%2Fjpd212959Citation Count: 5
- Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence2022RESTRICTEDTitle: Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligenceJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01318-7Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-022-01318-7Citation Count: 9